Learn More
Medchemexpress LLC Praliciguat | 1628730-49-3 | 99.35% | 534.36 | 100 MG

Supplier: Medchemexpress LLC HY10903950MG
Praliciguat is a potent and orally active soluble guanylate cyclase (sGC) activator. It increases cGMP via the nitric oxide (NO)-sGC pathway, inhibits the expression of proinflammatory cytokines and apoptosis, and promotes vasodilation. It is used for research on metabolic and cardiovascular diseases, such as hypertension, diabetes, and heart failure.
- Potent and orally active soluble guanylate cyclase (sGC) activator
- Increases cGMP via the nitric oxide (NO)-sGC pathway
- Inhibits the expression of proinflammatory cytokines
- Inhibits apoptosis
- Promotes vasodilation
- Stimulates soluble guanylate cyclase in HEK-293 cells with an EC50 of 197 nM
- Reduces arterial pressure (MAP) in normotensive and hypertensive rats
- Attenuates proteinuria in obese ZSF1 rats model of diabetic nephropathy
- Attenuates inflammation, fibrosis, and end-organ damage in the Dahl rats model of cardiorenal failure
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.